ARDD 2026 has announced that Kevin Duffin, VP, Aging Research at Eli Lilly, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.

ARDD 2026 has announced that Ruth Gimeno, VP Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development at Eli Lilly, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.

Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.

A new study led by an Iowa State University evolutionary biologist suggests an antenna-like cellular sensor that’s a growing focus in human health could play a central role in how turtles become male or female, which in most species is based on incubation temperature.

Understanding how heart muscle cells stop dividing and acquire the characteristics needed to sustain lifelong cardiac function remains one of the greatest challenges in cardiovascular biology. Leveraging human induced pluripotent stem (iPS) cell technology, a team led by Associate Professor Yoshinori Yoshida (Department of Clinical Application, CiRA, Kyoto University) and Associate Professor Antonio Lucena-Cacace  (WPI-PRIMe, The University of Osaka) has identified PRDM16 as an important regulator governing the balance between proliferation and maturation in human iPSC-derived cardiomyocytes.

Diallyl disulfide is an organosulfur compound derived from garlic, and R-carvone is a monoterpenoid derived from spearmint. Researchers processed these compounds into oil-in-water nanoemulsions and applied it to the adzuki bean beetle—a known legume pest. The researchers found that the nanoemulsions were highly toxic against the pest, suggesting that they could be a promising environmentally friendly alternative to synthetic pest-control agents.

A newly identified role for C/EBPγ reveals how lung adenocarcinoma cells simultaneously acquire invasive properties and strengthen DNA repair. The findings uncover a potential driver of treatment resistance and a promising therapeutic target.

A research team led by Professors Weiwei Jin and Wei Huang from China Agricultural University, in collaboration with Tianjin Agricultural University and the University of São Paulo in Brazil, elucidated how two anther-specific plasma membrane hexose transporters, ZmSWEET6a and ZmSWEET6b, coordinately regulate pollen wall development and cellular homeostasis. The study has been published online in The Crop Journal.

International research teams led by China Agricultural University and the Chinese Academy of Agricultural Sciences have identified and cloned a new semi-dwarfing gene, Sdd1 (semi-dwarf and dense-spike 1), that modulates plant height and spike architecture through a distinct hormonal balancing mechanism—offering breeders a fresh genetic resource to fine-tune wheat architecture.